These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1843183)

  • 61. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
    Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
    J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH; Eisen G; Charlap S; Strom JA
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Verapamil deleterious effects in chronic renal failure.
    Váquez C; Huelmos A; Alegría E; Errasti P; Purroy A
    Nephron; 1996; 72(3):461-4. PubMed ID: 8852497
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Massive overdose of sustained-release verapamil: a case report and review of literature.
    Ashraf M; Chaudhary K; Nelson J; Thompson W
    Am J Med Sci; 1995 Dec; 310(6):258-63. PubMed ID: 7503108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The toxicity of slow-release verapamil and chronic kidney disease].
    Huelmos A; Alegría E; Vázquez C
    Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
    [No Abstract]   [Full Text] [Related]  

  • 67. Verapamil toxicity: an unusual case report and review of the literature.
    Batalis NI; Harley RA; Schandl CA
    Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute toxic effects of sustained-release verapamil in chronic renal failure.
    Pritza DR; Bierman MH; Hammeke MD
    Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.